Aakaar Medical Technologies IPO - Details
Aakaar Medical Technologies is set to launch its Initial Public Offering (IPO) on June 20, 2025, with the subscription window closing on June 24, 2025. This is a Book Built Issue, aiming to raise approximately ₹27 crore, entirely through a fresh issue of shares. The face value of each share is ₹10.
The price band has been fixed between ₹68 and ₹72 per share. Investor allocation is structured with 50% reserved for Qualified Institutional Buyers (QIBs), 35% for retail investors, and 15% for High Net-worth Individuals (HNIs).
The allotment is expected to be finalized on June 25, 2025, and the stock is scheduled to be listed on the NSE on June 27, 2025.
From a financial perspective, the company posted a revenue of ₹61.76 crore in FY 2025, a significant increase from ₹46.27 crore in FY 2024. Net profit also rose sharply to ₹6.04 crore, up from ₹2.87 crore in the previous year.
Aakaar Medical Technologies IPO Market Lot
The Aakaar Medical Technologies IPO minimum market lot is 1600 shares with ₹1,15,200 application amount.
Application | Lot Size | Shares | Amount |
Retail Minimum | 1 | 1600 | ₹1,15,200 |
Retail Maximum | 1 | 1600 | ₹1,15,200 |
S-HNI Minimum | 2 | 3200 | ₹2,30,400 |
Aakaar Medical Technologies IPO Details
IPO Open Date: | June 20, 2025 |
IPO Close Date: | June 24, 2025 |
Face Value: | ₹10 Per Equity Share |
IPO Price Band: | ₹68 to ₹72 Per Share |
Issue Size: | Approx ₹27 Crores |
Fresh Issue: | Approx ₹27 Crores |
Issue Type: | Book Build Issue |
IPO Listing: | NSE SME |
Retail Quota: | Not more than 35% |
QIB Quota: | Not more than 50% |
NII Quota: | Not more than 15% |
Aakaar Medical Technologies IPO Valuation – FY2025
Explore key valuation metrics of Aakaar Medical Technologies IPO, including Earnings Per Share (EPS), Price-to-Earnings (P/E) Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV).
KPI | Values |
ROE: | 33.81% |
ROCE: | 21.02% |
EBITDA Margin: | 15.81% |
PAT Margin: | 9.81% |
Debt to equity ratio: | 0.98 |
Earning Per Share (EPS): | ₹6.13 (Basic) |
Price/Earning P/E Ratio: | 11.74 |
Return on Net Worth (RoNW): | 33.81% |
Net Asset Value (NAV): | ₹22.26 |
Aakaar Medical Technologies IPO Company Financial Report
In the financial year 2025, the company posted a revenue of ₹61.76 crores, marking a rise from ₹46.27 crores in 2024. Its net profit also grew to ₹6.04 crores in 2025, up from ₹2.87 crores in the previous year.
Period Ended | Revenue | Expense | Profit After Tax | Assets |
2023 | ₹32.88 | ₹29.78 | ₹2.15 | ₹23.23 |
2024 | ₹46.27 | ₹42.39 | ₹2.87 | ₹34.01 |
2025 | ₹61.76 | ₹53.68 | ₹6.04 | ₹51.85 |
Aakaar Medical Technologies IPO Dates
Aakaar Medical Technologies’ IPO will open for subscription on June 20 and will close on June 24. The allotment of shares is expected to be finalized by June 25, with the listing scheduled for June 27.
IPO Open Date: | June 20, 2025 |
IPO Close Date: | June 24, 2025 |
Basis of Allotment: | June 25, 2025 |
Refunds: | June 26, 2025 |
Credit to Demat Account: | June 26, 2025 |
IPO Listing Date: | June 27, 2025 |
Promoters of Aakaar Medical Technologies IPO
The promoters of the company are Dilip Ramesh Meswani and Bindi Dilip Meswani.
About Aakaar Medical Technologies IPO
Established in 2013, Aakaar Medical Technologies Ltd. is a prominent player in the medical and aesthetic device sector, offering an extensive range of cosmetic and dermatology-focused products. The company caters primarily to dermatologists, plastic surgeons, aesthetic doctors, and cosmetologists by supplying both its in-house developed items and high-quality international devices sourced from countries like South Korea, Spain, Italy, and Austria.
Its product lineup includes homecare and professional skincare solutions, injectables and contouring products, hair care essentials, growth serums and tablets, medifacial kits, and advanced devices used for treatments such as urinary incontinence, tattoo removal, pigmentation correction, skin rejuvenation, laser hair removal, and hair transplantation.
With a workforce of around 90 trained sales professionals and service engineers, Aakaar has built a strong distribution presence across several Indian states, including Delhi, Haryana, Punjab, Chandigarh, Uttarakhand, Uttar Pradesh, Bihar, West Bengal, Assam, Gujarat, Madhya Pradesh, Maharashtra, Karnataka, Telangana, and Tamil Nadu.
Peer Group Comparison
Company | EPS | PE Ratio | RoNW % | NAV | Income |
NA | – | – | – | – | – Cr. |
Objects of the IPO
To meet the company’s working capital requirements
For general business and corporate purposes
Merchant Bankers
- Indorient Financial Services Ltd
Company Address
Aakaar Medical Technologies Limited
801, Heritage Plaza,
Telli Galli Cross Road
Andheri (East),
Mumbai, Maharashtra, 400069
Phone: +91 84528 44024
Email: [email protected]
Website: https://aakaarmedical.in/
Aakaar Medical Technologies IPO Registrar
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: [email protected]
Website: https://ipo.bigshareonline.com/IPO_Status.html
Check Grey market premium at below
(GMP)